Trial Profile
Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients: Clinical Impact of Genetic Variation in Statin Disposition
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacogenomic; Pharmacokinetics
- 29 Jan 2019 Status changed from recruiting to completed.
- 18 Jul 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
- 18 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.